Literature DB >> 12165517

Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene.

Farha H Vasanwala1, Saritha Kusam, Lisa M Toney, Alexander L Dent.   

Abstract

The B cell lymphoma-6 (BCL-6) transcriptional repressor protein is an important regulator of B cell differentiation and is strongly implicated in the development of B cell lymphoma. Expression of the Blimp-1 transcription factor, which is critical for promoting B cell differentiation into plasma cells, is repressed by BCL-6. We have investigated the mechanism for how BCL-6 represses Blimp-1 transcription, and have found that BCL-6 regulates the Blimp-1 promoter through a novel mechanism involving AP-1 elements. Specifically, BCL-6 is a potent repressor of transcriptional activity mediated by AP-1 factors. We found that the zinc-finger region of BCL-6 interacts with c-Jun, JunB, and JunD proteins but does not bind c-Fos or Fra-2 proteins. An estrogen receptor ligand binding domain fusion with the BCL-6 zinc finger domain can act as a estrogen-inducible dominant negative protein and increase AP-1 activity in BCL-6(+) cells but not in BCL-6(-) cells, indicating that endogenous BCL-6 represses AP-1 activity. Additionally, we have confirmed a specific interaction between c-Jun and the zinc finger domain of BCL-6 in vivo using a mammalian two-hybrid assay. Repression of AP-1 function by BCL-6 may be a key mechanism for how BCL-6 regulates gene expression to control inflammation, lymphocyte differentiation, and lymphomagenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165517     DOI: 10.4049/jimmunol.169.4.1922

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  75 in total

1.  BCL6 canalizes Notch-dependent transcription, excluding Mastermind-like1 from selected target genes during left-right patterning.

Authors:  Daisuke Sakano; Akiko Kato; Nisarg Parikh; Kelly McKnight; Doris Terry; Branko Stefanovic; Yoichi Kato
Journal:  Dev Cell       Date:  2010-03-16       Impact factor: 12.270

Review 2.  Immunological function of Blimp-1 in dendritic cells and relevance to autoimmune diseases.

Authors:  Sun Jung Kim
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

3.  Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets.

Authors:  Micah D Gearhart; Connie M Corcoran; Joseph A Wamstad; Vivian J Bardwell
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

4.  Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas.

Authors:  B Belinda Ding; J Jessica Yu; Raymond Y-L Yu; Lourdes M Mendez; Rita Shaknovich; Yonghui Zhang; Giorgio Cattoretti; B Hilda Ye
Journal:  Blood       Date:  2007-10-19       Impact factor: 22.113

5.  Attenuation of antigenic immunogenicity by kynurenine, a novel suppressive adjuvant.

Authors:  Zhiqing Duan; Yunqing Duan; Huangui Lei; Ningzhu Hu; Jiandong Shi; Dong Shen; Xi Wang; Yunzhang Hu
Journal:  Hum Vaccin Immunother       Date:  2014-02-28       Impact factor: 3.452

6.  Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.

Authors:  Dina Schneider; Maria A Manzan; Byung Sun Yoo; Robert B Crawford; Norbert Kaminski
Journal:  Toxicol Sci       Date:  2009-02-23       Impact factor: 4.849

7.  IL-21 and CD40L synergistically promote plasma cell differentiation through upregulation of Blimp-1 in human B cells.

Authors:  B Belinda Ding; Enguang Bi; Hongshan Chen; J Jessica Yu; B Hilda Ye
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422

8.  Revealing global regulatory perturbations across human cancers.

Authors:  Hani Goodarzi; Olivier Elemento; Saeed Tavazoie
Journal:  Mol Cell       Date:  2009-12-11       Impact factor: 17.970

Review 9.  Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas.

Authors:  Samir Parekh; Gilbert Privé; Ari Melnick
Journal:  Leuk Lymphoma       Date:  2008-05

Review 10.  Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation.

Authors:  Shane Crotty; Robert J Johnston; Stephen P Schoenberger
Journal:  Nat Immunol       Date:  2010-01-19       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.